Discover Excellence

Endovascular Treatment Of Superior Vena Cava Syndrome Vdm

endovascular Treatment Of Superior Vena Cava Syndrome Vdm
endovascular Treatment Of Superior Vena Cava Syndrome Vdm

Endovascular Treatment Of Superior Vena Cava Syndrome Vdm Endovascular treatment of superior vena cava syndrome abstract: superior vena cava syndrome (svcs) is a medical emergency that requires an immediate evaluation and therapy as it can be fatal. nowadays, svcs is mostly caused by lung or mediastinal malignant tumors. we would like to emphasize the crucial role of superior vena cava stenting by. Results. superior vena cava occlusion repair was not possible in one oligosymptomatic patient with a very severe lesion. technical success was achieved in 96.4%. there were two deaths, one due to pulmonary embolism, 24 hours after a successful procedure, and the other due to compression of the airways by tumor mass some hours after the procedure.

endovascular Treatment Of Superior Vena Cava Syndrome Vdm
endovascular Treatment Of Superior Vena Cava Syndrome Vdm

Endovascular Treatment Of Superior Vena Cava Syndrome Vdm Superior vena cava (svc) syndrome is a collection of clinical signs and symptoms resulting from partial or complete obstruction of blood flow through the svc. this obstruction is most commonly a result of thrombus formation or tumor infiltration of the vessel wall. the svc is formed by the junction of the left and right innominate (brachiocephalic) veins and is tasked with returning blood from. Superior vena cava (svc) syndrome comprises a constellation of clinical signs and symptoms caused by obstruction of blood flow through the svc. the management of patients with life threatening svc syndrome is evolving from radiation therapy to endovascular therapy as the first line treatment. there is a paucity of data and societal guidelines. Superior vena cava (svc) syndrome is caused by the obstruction of the svc and can result in significant morbidity and mortality. in contemporary practice, endovascular therapy (et) has become the standard of care for a majority of these patients. It was concluded that the stent treatment for superior vena cava syndrome is a safe treatment with good clinical effect in patients with superior vena cava syndrome in the terminal phase of.

Comments are closed.